Transcriptomics

Dataset Information

0

IRAK1/4 and BET bromodomain inhibitions converge on NF-κB blockade and display synergistic antitumor activity in ABC-DLBCL with MYD88L265P mutation


ABSTRACT: Diffuse large B cell lymphoma cell lines of the activated B cell subtype (ABC-DLBCL) were treated for 6h with IRAK1/4 inhibitor (50µM) followed or not by a 18h exposure to 500 nM CPI203 We used microarrays to uncover the mechanisms underlying IRAKi+BETi activity in ABC-DLBCL

ORGANISM(S): Homo sapiens

PROVIDER: GSE159915 | GEO | 2020/10/24

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-12-01 | GSE64586 | GEO
| PRJNA670877 | ENA
2012-08-16 | GSE32456 | GEO
2010-12-30 | GSE22900 | GEO
2022-08-24 | GSE211549 | GEO
2011-07-01 | GSE22901 | GEO
2014-08-01 | GSE58791 | GEO
2016-01-07 | E-GEOD-69383 | biostudies-arrayexpress
2010-12-30 | E-GEOD-22900 | biostudies-arrayexpress
2019-04-19 | GSE116288 | GEO